Certara Inc (CERT)

$13.45 +0.38 (2.91%)
Market Cap 2.10B
Revenue (ttm) 385.15M
Net Income (ttm) -12.05M
EPS (ttm) N/A
PE Ratio 40.00
Forward PE 47.89
Profit Margin -3.13%
Debt to Equity Ratio 0.27
Volume 1,932,700
Avg Vol 1,653,904
Day's Range N/A - N/A
Shares Out 160.62M
Stochastic %K 84%
Beta 1.45
Analysts Sell
Price Target $14.50

Company Profile

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scienti...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 237 8272
Address:
4 Radnor Corporate Center, Suite 350, Radnor, United States
JarvisFlow
JarvisFlow Oct. 2 at 2:04 PM
Barclays has adjusted their stance on Certara ( $CERT ), setting the rating to Overweight with a target price of 14 → 16.
0 · Reply
notreload_ai
notreload_ai Sep. 30 at 9:29 AM
Craig-Hallum started covering $CERT with a Buy rating and a $16 price target. They see potential in the company's near-term prospects and long-term growth, making it a good investment opportunity.
0 · Reply
JarvisFlow
JarvisFlow Sep. 29 at 2:22 PM
Craig-Hallum updates rating for Certara ( $CERT ) to Buy, target set at 16.
0 · Reply
parcha
parcha Sep. 23 at 10:22 PM
Final Trade: CERT, GDX, IWM, MPC $GDX $IWM $MPC $CERT https://www.cnbc.com/video/2025/09/23/final-trade-cert-gdx-iwm-mpc.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 7:06 AM
$CERT Great piece that accurately captures CERT's current position. So if you want to refresh your understanding of CERT or learn about CERT for the first time, this is essential reading. https://beyondspx.com/quote/CERT/analysis/certara-s-ai-powered-biosimulation-unlocking-drug-development-s-next-frontier-nasdaq-cert
0 · Reply
TrendNova
TrendNova Aug. 23 at 8:53 AM
$CERT Certara Inc is facing biopharma outsourcing volatility and competitive pressure
0 · Reply
JarvisFlow
JarvisFlow Aug. 7 at 5:20 PM
UBS has updated their rating for Certara ( $CERT ) to Buy with a price target of 15.
0 · Reply
MathMan101
MathMan101 Aug. 7 at 2:36 PM
$CERT Premiere AI play in biotech.
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 12:30 PM
Keybanc has updated their rating for Certara ( $CERT ) to Overweight with a price target of 15.
0 · Reply
ZacksResearch
ZacksResearch Jul. 8 at 5:27 PM
$VEEV soars nearly 29% in 3 months — what’s driving the rally? 🚀 📈 Q1 fiscal 2026 revenues up 17%, with a robust 46% adjusted operating margin 🔧 Vault CRM adoption accelerates, AI features on the horizon 🌟 Outperforming sector + peers like $IQV, $CERT, $HCAT Discover why VEEV is a Zacks Rank #2 (Buy) here 👉 https://www.zacks.com/stock/news/2567637/veev-rises-29-in-3-months-should-you-buy-the-stock-now-or-wait?cid=sm-stocktwits-2-2567637-body-985&ADID=SYND_STOCKTWITS_TWEET_2_2567637_BODY_985
0 · Reply
Latest News on CERT
Final Trade: CERT, GDX, IWM, MPC

Sep 23, 2025, 6:34 PM EDT - 13 days ago

Final Trade: CERT, GDX, IWM, MPC

GDX IWM MPC

Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:40 PM EDT - 26 days ago

Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Sep 9, 2025, 12:21 PM EDT - 27 days ago

Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Sep 4, 2025, 8:00 AM EDT - 4 weeks ago

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara to Participate in Upcoming Investor Conferences

Sep 2, 2025, 4:15 PM EDT - 4 weeks ago

Certara to Participate in Upcoming Investor Conferences

Cerrado Gold Inc. (CRDOF) Q2 2025 Earnings Call Transcript

Aug 25, 2025, 1:32 PM EDT - 6 weeks ago

Cerrado Gold Inc. (CRDOF) Q2 2025 Earnings Call Transcript

Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 10:24 PM EDT - 2 months ago

Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript

Certara Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:15 PM EDT - 2 months ago

Certara Reports Second Quarter 2025 Financial Results

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Aug 4, 2025, 2:00 AM EDT - 2 months ago

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Jul 31, 2025, 4:15 PM EDT - 2 months ago

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences

Jul 11, 2025, 3:09 AM EDT - 3 months ago

Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Jul 9, 2025, 4:15 PM EDT - 3 months ago

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Jul 8, 2025, 8:00 AM EDT - 3 months ago

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:22 PM EDT - 5 months ago

Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript

Certara Reports First Quarter 2025 Financial Results

May 5, 2025, 4:15 PM EDT - 5 months ago

Certara Reports First Quarter 2025 Financial Results

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Apr 14, 2025, 2:08 PM EDT - 6 months ago

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Apr 14, 2025, 8:15 AM EDT - 6 months ago

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Buy Certara After The FDA Announcement

Apr 11, 2025, 1:15 PM EDT - 6 months ago

Buy Certara After The FDA Announcement

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

Apr 11, 2025, 10:44 AM EDT - 6 months ago

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

CRL SLP

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Apr 1, 2025, 8:00 AM EDT - 6 months ago

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Mar 5, 2025, 4:15 PM EST - 7 months ago

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara, Inc. (CERT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 8:03 PM EST - 7 months ago

Certara, Inc. (CERT) Q4 2024 Earnings Call Transcript

Certara Reports Fourth Quarter 2024 Financial Results

Feb 26, 2025, 4:15 PM EST - 7 months ago

Certara Reports Fourth Quarter 2024 Financial Results

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Jan 29, 2025, 4:15 PM EST - 8 months ago

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 15, 2025, 7:55 AM EST - 9 months ago

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Final Trade: CERT, XLE, DAL, OKTA

Jan 10, 2025, 7:14 PM EST - 9 months ago

Final Trade: CERT, XLE, DAL, OKTA

OKTA XLE DAL

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:15 PM EST - 9 months ago

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Dec 2, 2024, 4:15 PM EST - 11 months ago

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript

Nov 6, 2024, 9:09 PM EST - 11 months ago

Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript

Certara Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:15 PM EST - 11 months ago

Certara Reports Third Quarter 2024 Financial Results

Certara to Participate in the Stephens Annual Investment Conference

Oct 28, 2024, 4:15 PM EDT - 1 year ago

Certara to Participate in the Stephens Annual Investment Conference

Certara Appoints John Reynders as New Independent Board Member

Oct 16, 2024, 4:15 PM EDT - 1 year ago

Certara Appoints John Reynders as New Independent Board Member

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Oct 9, 2024, 4:15 PM EDT - 1 year ago

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Certara Completes Acquisition of Chemaxon

Oct 2, 2024, 4:15 PM EDT - 1 year ago

Certara Completes Acquisition of Chemaxon

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

Sep 27, 2024, 6:37 PM EDT - 1 year ago

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

KNX LULU NEE

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Aug 15, 2024, 4:15 PM EDT - 1 year ago

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Certara, Inc. (CERT) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 7:36 PM EDT - 1 year ago

Certara, Inc. (CERT) Q2 2024 Earnings Call Transcript

Certara Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:15 PM EDT - 1 year ago

Certara Reports Second Quarter 2024 Financial Results

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Jul 9, 2024, 4:45 PM EDT - 1 year ago

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

Jul 2, 2024, 4:15 PM EDT - 1 year ago

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

Jun 17, 2024, 8:00 AM EDT - 1 year ago

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

Certara to Participate in the Jefferies Global Healthcare Conference

May 29, 2024, 4:15 PM EDT - 1 year ago

Certara to Participate in the Jefferies Global Healthcare Conference

Certara Appoints New Chief Human Resources Officer & General Counsel

May 21, 2024, 8:00 AM EDT - 1 year ago

Certara Appoints New Chief Human Resources Officer & General Counsel

Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript

May 8, 2024, 3:56 AM EDT - 1 year ago

Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript

Certara Reports First Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Certara Reports First Quarter 2024 Financial Results

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

Apr 16, 2024, 8:00 AM EDT - 1 year ago

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference

Certara Inc. (CERT) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 9:33 PM EST - 1 year ago

Certara Inc. (CERT) Q4 2023 Earnings Call Transcript

Certara Reports Fourth Quarter 2023 Financial Results

Feb 29, 2024, 4:10 PM EST - 1 year ago

Certara Reports Fourth Quarter 2023 Financial Results

JarvisFlow
JarvisFlow Oct. 2 at 2:04 PM
Barclays has adjusted their stance on Certara ( $CERT ), setting the rating to Overweight with a target price of 14 → 16.
0 · Reply
notreload_ai
notreload_ai Sep. 30 at 9:29 AM
Craig-Hallum started covering $CERT with a Buy rating and a $16 price target. They see potential in the company's near-term prospects and long-term growth, making it a good investment opportunity.
0 · Reply
JarvisFlow
JarvisFlow Sep. 29 at 2:22 PM
Craig-Hallum updates rating for Certara ( $CERT ) to Buy, target set at 16.
0 · Reply
parcha
parcha Sep. 23 at 10:22 PM
Final Trade: CERT, GDX, IWM, MPC $GDX $IWM $MPC $CERT https://www.cnbc.com/video/2025/09/23/final-trade-cert-gdx-iwm-mpc.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 7:06 AM
$CERT Great piece that accurately captures CERT's current position. So if you want to refresh your understanding of CERT or learn about CERT for the first time, this is essential reading. https://beyondspx.com/quote/CERT/analysis/certara-s-ai-powered-biosimulation-unlocking-drug-development-s-next-frontier-nasdaq-cert
0 · Reply
TrendNova
TrendNova Aug. 23 at 8:53 AM
$CERT Certara Inc is facing biopharma outsourcing volatility and competitive pressure
0 · Reply
JarvisFlow
JarvisFlow Aug. 7 at 5:20 PM
UBS has updated their rating for Certara ( $CERT ) to Buy with a price target of 15.
0 · Reply
MathMan101
MathMan101 Aug. 7 at 2:36 PM
$CERT Premiere AI play in biotech.
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 12:30 PM
Keybanc has updated their rating for Certara ( $CERT ) to Overweight with a price target of 15.
0 · Reply
ZacksResearch
ZacksResearch Jul. 8 at 5:27 PM
$VEEV soars nearly 29% in 3 months — what’s driving the rally? 🚀 📈 Q1 fiscal 2026 revenues up 17%, with a robust 46% adjusted operating margin 🔧 Vault CRM adoption accelerates, AI features on the horizon 🌟 Outperforming sector + peers like $IQV, $CERT, $HCAT Discover why VEEV is a Zacks Rank #2 (Buy) here 👉 https://www.zacks.com/stock/news/2567637/veev-rises-29-in-3-months-should-you-buy-the-stock-now-or-wait?cid=sm-stocktwits-2-2567637-body-985&ADID=SYND_STOCKTWITS_TWEET_2_2567637_BODY_985
0 · Reply
smartkarma
smartkarma Jun. 26 at 9:04 PM
$CERT | Certara Inc.: Is The Software Revenue & Bookings Growth Here To Stay? "Certara's performance in the first quarter of 2025 shows a blend of favorable developments and continuing challenges, reflecting its position in..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/certara-inc-is-the-software-revenue-bookings-growth-here-to-stay
0 · Reply
DeMampCamp
DeMampCamp Jun. 13 at 2:21 PM
$CERT Gap fill coming, load the boat!
0 · Reply
swingingtech
swingingtech Jun. 12 at 11:19 AM
$VONE $CERT $BIRK $TREX https://wallstreetwaves.com/unlocking-value-vones-potential-to-reach-310/
0 · Reply
sweetpotatocow
sweetpotatocow May. 16 at 12:23 AM
$CERT what in the world is going on with the daily chart on this, LOL?
0 · Reply
Estimize
Estimize May. 14 at 8:03 PM
Wall St is expecting 0.09 EPS for $CERT Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow May. 8 at 5:12 PM
Barclays has adjusted their stance on Certara ( $CERT ), setting the rating to Overweight with a target price of 11 → 14.
0 · Reply
JarvisFlow
JarvisFlow May. 6 at 2:30 PM
JMP Securities has adjusted their stance on Certara ( $CERT ), setting the rating to Market Perform.
0 · Reply
Estimize
Estimize May. 6 at 12:09 PM
$CERT reported 0.14 EPS and 106.00 revenue for Q1. http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_content=CERT&utm
0 · Reply
Doozio
Doozio May. 1 at 11:25 PM
If the DUOL is won then another $CERT ified Thursday 🐑 low before a gap n go on eps next week INTA 🐒🍌🧠⏰♾️
0 · Reply
Doozio
Doozio Apr. 23 at 11:42 AM
$TSLA MNDY Thursday 🐑 ♾️ was epically $CERT ified ❤️👑🌈🦄
0 · Reply
Doozio
Doozio Apr. 22 at 4:45 PM
👁️ $SPY once upon a ⏰ there was a story of a MNDY 🐑. Then he went Thursday 🐑. Then YO got so 🐑 y it went 🐑♾️ n they went Thursday n MNDY 🐑 until a $CERT fed bahhhtom was in n da 🧠 slowly returned! https://youtu.be/Dol10tMdScg?si=LljK764eSzihrC5t
0 · Reply
Doozio
Doozio Apr. 21 at 7:37 PM
$XBI can YO $CERT ify da end of da 🐑 is a return of a 🧠 $DAWN ?
0 · Reply